Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 77/100

Termination Rate

22.2%

2 terminated out of 9 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results71% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
P 2 (1)
P 4 (1)

Trial Status

Completed5
Unknown2
Terminated2

Trial Success Rate

71.4%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (9)

Research Network

Activity Timeline